Valley Clinical Research Inc El Centro, CA - 92243

Valley Clinical Research Inc is categorized under Research and Development Laboratories in El Centro, CA and active since 1999.

Valley Clinical Research Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Edward Cherlin at the company’s single location by writing to 230 South 8th St, El Centro, California CA 92243 or by phoning (480) 290-1480. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Valley Clinical Research Inc
Contact Person: Edward Cherlin
Address: 230 South 8th St, El Centro, California 92243
Phone Number: (480) 290-1480
Annual Revenue (USD): $100.000 to $499.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Valley Clinical Research Inc was started in 1999 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Edward Cherlin for inquiries that concern Valley Clinical Research Inc by calling the company number (480) 290-1480, as your correspondence is most welcome. Additionally, the physical location of the single location of Valley Clinical Research Inc can be found at the coordinates as well as the street address 230 South 8th St in El Centro, California 92243.

For its online presence, you may visit Valley Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.